The purpose of this study was to predict implantable cardioverter defibrillator (ICD) shocks using demographic and clinical characteristics in the first year after implantation for secondary prevention of cardiac arrest. A prospective design was used to follow 168 first-time ICD recipients over 12 months. Demographic and clinical data were obtained from medical records at the time of ICD insertion. Implantable cardioverter defibrillator shock data were obtained from ICD interrogation reports at hospital discharge, 3, 6, and 12 months. Logistic regression was used to predict ever receiving an ICD shock using background characteristics. Patients received an ICD for secondary prevention of sudden cardiac arrest, they were 64.1 years old, 89% were white, 77% were male, with a mean (SD) ejection fraction of 33.7% (14.1%). The cumulative percentage of ever receiving an ICD shock was 33.3% over 1 year. Three variables predicted shocks in the first year: history of chronic obstructive pulmonary disease (COPD) (odds ratio [OR], 4.42; 95% confidence interval [CI], 1.2Y16.4; P = .03), history of congestive heart failure (OR, 3.55; 95% CI, 1.4Y9.3; P = .01), and documented ventricular tachycardia (VT) at the time of ICD implant (OR, 10.05; 95% Cl, 1.8Y55.4; P = .01). High levels of anxiety approached significance (OR = 2.82; P = .09). The presence of COPD, congestive heart failure, or VT at ICD implant was a significant predictor of receiving an ICD shock in the first year after ICD implantation. Because ICD shocks are distressing, painful, and associated with greater mortality, healthcare providers should focus attention on prevention of shocks by controlling VT, careful management of HF symptoms, reduction of the use of short acting " agonist medications in COPD, and perhaps recognizing and treating high levels of anxiety.
R eceiving shocks is a physically painful and emotionally distressing event experienced by those living with an implantable cardioverter defibrillator (ICD).
1Y5 Shocks decrease quality of life and increase healthcare utilization. 2 From multivariate risk profiles, approximately 50% to 60% of patients will receive an ICD shock within 9 T 11 months after implantation, an average of 2.3 shocks per patient per year. 6Y9 The longer a person has had the ICD, the less accurate he/she is at remembering how many shocks he/she received. 4 Past predictors of receiving an ICD shock after implantation include inducible monomorphic ventricular tachycardia (VT) or sustained or nonsustained VT at time of ICD implantation, 10Y12 history of VT at the time of myocardial infarction (MI), 13 sedentary life style, 5 history of renal failure, 14 ejection fraction less than or equal to 35%, 12 emotional distress, 11, 15 depression, 16 smoking, 17 not taking "-blocker medication, 13 and elevated B-type natriuretic peptide above the 50th percentile (283 ng/L). 18 Inappropriate ICD shocks can be caused by problems associated with the device, such as lead failure, physical damage to the device, far field atrial sensing, diaphragmatic potentials, T wave oversensing, and electrical noise. 1, 19 In addition, atrial fibrillation, 2, 20 supraventricular arrhythmias, New York Heart Association class I heart failure, 20 and single chamber ICDs are associated with more inappropriate ICD shocks.
After having an ICD implanted, any shock increases the chance of cardiac mortality by 2-fold. 21 Those who experience frequent shocks are at a high risk of experiencing cardiac arrhythmia and sudden cardiac death even when shocks are appropriate. 1 Pathological studies have demonstrated fibrosis and acute cellular injury in the hearts of patients who have had recent shocks. 22 The occurrence of electrical storms from an ICD (93 distinct ICD shocks in a 24-hour period) is related to increased morbidity and mortality. These deaths usually occurred within the first 3 months after an electrical storm. 22, 23 After an ICD shock, patients express high levels of anxiety, anger, stress, depression, fear, and poor quality of life. 24, 25 Implantable cardioverter defibrillator shocks lead to greater psychological distress for family members as well. 24, 26 The experience of having a shock erodes psychological defense mechanisms and confidence, creating feelings of uncertainty about the future. 5, 27 Having one or more shocks within the first year after implantation is associated with a significant decline in reported physical and mental functioning. 3 Anxiety scores of those receiving ICD shocks have been reported to be similar to those with panic disorder. 27 Receiving 5 or more shocks 2 or 6 or more shocks has been documented to result in reduced patient well-being, whether ICD shocks are appropriate or inappropriate. 28 Receiving multiple and repeated ICD shocks results in posttraumatic stress disorder or reactive depression in approximately 15% to 30% of the patients who are living with an ICD. 29, 30 Implantable cardioverter defibrillator shock intensity can be rather severe, rated as 4.0 on a 0 to 5 scale. 4 After an ICD shock, individuals are fearful that an activity will trigger another shock. Multiple shocks were the most frightening for patients, causing them to wonder if the device was really working or if the ICD would even kill them. 24, 25 It is not uncommon for individuals to avoid activities that have caused an ICD therapy or an activity that they perceive might result in an ICD therapy. This avoidance of activities that might cause an ICD discharge has been associated with reduced quality of life. 4, 5, 27 This decreased functioning, if present, occurs during the first 6 months after implantation and is followed by acceptance as the patient realizes that the device is essential for his/her well-being. 5 Implantable cardioverter defibrillator shocks can act as an ''illness scoreboard,'' with the more shocks a person receives being correlated with a greater illness burden. 27 If healthcare providers can predict who is most likely to receive an ICD shock after implantation, interventions to prevent and avoid ICD shocks can be implemented. In doing so, the quality of life and overall adjustment of patients will be enhanced and mortality will be reduced.
The purpose of this article was to report baseline clinical characteristics that predicted the receipt of an ICD shock during the first year after implantation in persons who had an ICD for the secondary prevention of sudden cardiac arrest (SCA). This is a secondary analysis of data collected initially to test the effects of a nursing intervention on psychological functioning in the first year subsequent to ICD implantation.
Methods
This study used a longitudinal randomized clinical trial to test the effects of a combined education and telephone intervention delivered by trained cardiovascular nurses when compared with usual care. Study participants were SCA survivors or those with malignant ventricular arrhythmias who received an ICD for the first time. Measurements were collected at hospital discharge and at 3, 6, and 12 months after hospitalization. All research procedures were reviewed and approved by hospital institutional review boards and the academic institutional review board before contact with potential participants.
Protocol
Potential participants were identified during hospitalization by site coordinators in 10 medical centers in the Pacific Northwest. Those interested in the study were contacted through telephone call the day after hospital discharge by the researchers, who explained the study and obtained verbal consent to participate. Written informed consent and baseline measures were completed during the first week after hospital discharge. Participants were recruited to participate in a nursing intervention study that focused on psychological recovery after ICD implantation. While the participants were in that study, ICD shock data from each of them were recorded. The nursing intervention was a telephone intervention that was delivered during the first 8 weeks after hospital discharge. The nursing intervention program had no effect on the number of ICD shocks received by participants; therefore, the entire group was combined for these analyses.
Sample
Study participants (N = 168) included individuals who had experienced a first SCA or life-threatening arrhythmia requiring ICD implantation for secondary prevention based on established guidelines. 31 Additional criteria included having the ability to read, speak, and write English; having telephone access; and willingness to be followed for 1 year. Individuals were excluded from the study if they had significant clinical comorbidities that impaired cognitive and physical functioning or if they were younger than 21 years. Confirmation of the need for ICD implantation was verified through medical records and electrophysiological testing reports. All participants were screened with the Short Blessed cognitive screening tool 32 at recruitment. Short Blessed scores of 10 or greater indicated cognitive impairment too severe for participation. 33 Two individuals were screened out based on the Short Blessed criteria. All participants in this study received usual care as provided by the hospital and healthcare providers in the community. Usual care consisted of standardized hospital-based education about the ICD and outpatient follow-up clinic visits at times and frequency as designated by their current healthcare providers.
Implantable Cardioverter Defibrillator Shock Measurement
Implantable cardioverter defibrillator shock information was collected subjectively from participants as they experienced an ICD shock and reported it to their healthcare provider. Then ICD interrogation reports of ICD shocks were obtained from the provider who completed the ICD interrogation. All ICD shocks received were included in these analyses. Participants who were enrolled into the clinical trial had to have experienced a ventricular arrhythmia and/or out of hospital ventricular fibrillation (VF) cardiac arrest to be enrolled in the study. Patients were not enrolled in the study if they received an ICD for primary prevention of SCA without having a previous history of ventricular arrhythmia. There were no patients in the study who had a biventricular ICD implanted.
Clinical Variables
Baseline demographic and clinical variables were collected from self-report and/or from medical records review at the time of study entry. Anxiety was measured using the state version of the State-Trait Anxiety Inventory. 34 Depression was measured using the Centers for Epidemiologic StudiesYDepression Scale. 35 
Analysis
Baseline demographic and clinical characteristics were used to create a multivariate risk profile for predicting those who did or did not receive a shock in the first year subsequent to receiving an ICD. Data are summarized as mean (SD). The significance was defined as P e .05 using a 2-tailed test. A statistical model for predicting ever receiving an ICD shock over 12 months after ICD implantation was created using a stepwise multiple logistic regression model. Baseline demographic and clinical characteristics were used as the independent variables in the analysis. Statistical significance of bivariate relationships between the outcome variable of ever receiving an ICD shock and the independent variables was evaluated by either # 2 statistics for categorical variables or analysis of variance for continuous variables. The effect of the independent variables on the outcome was measured by odds ratio (OR). All statistical analyses were conducted using the SPSS version 14.0 (SPSS, Chicago, Illinois).
Results

Sample Characteristics
Over a 21-month period, 243 SCA survivors were referred for participation in the study. Of these 243 survivors, 8 (3.3%) did not return baseline questionnaires within 1 month of hospital discharge and were not offered admission to the study, 28 (11.5%) were ineligible because of no documented ventricular arrhythmia, 18 (7.4%) did not want to continue after reviewing the questionnaire packet, 20 (8.2%) refused participation on the telephone or could not be contacted after hospital discharge, and 1 person wanted to be paid more money to participate. The remaining 168 (69%) SCA survivors were followed for 1 year after ICD implantation. The average age was 64.1 (12.28) years, with most participants being white (89%) and men (76%). Most SCA survivors were in a relationship with a spouse or significant intimate partner (79%), and 98.2% lived in an independent living situation with that partner. At baseline, the cognitive capabilities of participants resulted in an average of 2 ''errors'' on the Short Blessed screening tool. The average combined household income was $30,000 to 49,999 (33%), and more than half of the participants (64.3%) were retired from full-time work. The average level of education was ''some college'' for 26.6%, and 41.1% had a 2-year college degree or higher degree ( Table 1) .
The average body mass index was 28.32 cm/m 3 , defined as overweight by the National Heart, Lung, and Blood Institute criteria. A total of 116 of 168 individuals were considered overweight at the time of study entry. The average ejection fraction for the sample was 33.7%. The most common reason for ICD implantation was documented VF or VT at electrophysiological testing, with 39% having had survived out of hospital VF cardiac arrest. Charlson comorbidity index scores 17 averaged 4.34, indicating that persons in the study had a number of other comorbid disease conditions at the time or study entry.
ICD Shocks
Of a total of 168 patients at baseline hospital discharge, 51 received 1 ICD shock in the first year, a cumulative shock event rate of 33.3%. Three
Predictors of ICD Shocks During First Year 23 individuals (1.7%) received 1 or more ICD shocks while they were still hospitalized and before going home. The cumulative ICD shock rate was the following: 12.6% received an ICD shock between hospital discharge and 1 month; 7.5%, between 1 and 3 months; 7.1%, between 3 and 6 months; and 17.3%, between 6 and 12 months. Of the 51 who received an ICD shock, 34 (66.6%) received only 1 ICD shock in the first year. Twelve of these 51 (23.5%) received 4 or more shocks in a 24-hour period during the 12-month follow-up period. The baseline clinical characteristics that were associated with receiving an ICD shock between 1 and 3 months were (1) ejection fraction (EF) of less than or equal to 35% and (2) Charlson comorbidity score. Characteristics associated with receiving an ICD shock between 3 and 6 months were (1) documented VT lasting more than 10 seconds and (2) not taking a "-blocker. Characteristics associated with receiving an ICD shock between 6 and 12 months were (1) documented VT lasting more than 30 seconds and (2) a history of congestive heart failure (CHF) ( Table 2) .
Comparisons between participants who did or did not experience an ICD shock in the 12-month period after ICD implantation were conducted using # 2 analyses (Table 3 ). There were significant differences between the groups in reason for ICD implantation, history of chronic obstructive pulmonary disease (COPD), and CHF. Participants who had experienced an ICD shock in 12 months after implantation had a greater occurrence of COPD or CHF or had their ICD implanted for unmonitored syncope with VT lasting more than 10 seconds.
Multiple logistic regression analyses were used to predict the baseline clinical characteristics associated with receiving an ICD shock within 12 months. All variables were entered into the model simultaneously (Table 4) . Characteristics with a predictive value less than 0.50 were excluded from the final model. The predictors of receiving a shock within the first 12 months after having an ICD placed included (1) COPD (OR = 3.10; P = .04), (2) CHF (OR = 3.10; P = .04), and (3) implantation of ICD for unmonitored syncope and VT lasting for more than 10 seconds (OR = 4.45; P = .02). This was a significant model (P G .001), and it accounted for 11% of the variance in having a shock within 12 months. Statistics indicated that the model fit the data well (Hosmer and Lemeshow, # 2 = 0.52; P = .77). High anxiety at the time of ICD implanted approached statistical significance (OR = 2.82; P = .09).
During the 12-month follow-up period, 5 of 168 (2.9%) died from congestive heart failure. Of those 5 who died, 1 person had received at least 1 ICD shock during the first year after receiving an ICD. However, ICD shocks were not found to be a significant predictor of mortality in this study.
Discussion
The results of this study indicate that one-third (33.3%) of patients who received an ICD for the Abbreviations: CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; VT, ventricular tachycardia. Predictors of ICD Shocks During First Year 25 secondary prevention of SCA experienced at least 1 shock in the first year after implantation. Having a medical history of CHF or COPD or receiving an ICD for documented VT was more often associated with receiving an ICD shock than those not having these characteristics. Implantable cardioverter defibrillator shocks in our study were not significantly associated with an increased mortality. These findings are consistent with other reports from the literature. Moreover, these data were collected prospectively, whereas other studies have collected the data retrospectively, relying on the accuracy of medical record entries and patient reports. Recent reports that have examined predictors of ICD shock within the first year after implantation point to reason for ICD implantation, renal insufficiency, smoking, use of "-blockers, and clinical risk scores. Clinical risk scores are derived based on the reason for implantation, serum creatinine level, and QRS duration. This new scoring method is highly predictive of time to appropriate ICD shock. 36 A new finding of this study was the association between occurrence of ICD shocks and a history of COPD. This may be due to the acceleration of heart rate frequently seen with the use of short-acting metered-dose inhalers containing "-agonists. 37 Elevated heart rate frequently precedes an ICD shock. Furthermore, hypokalemia occurs with the administration of "-agonists because of the intracellular shift of potassium into skeletal muscle. Hypokalemia is a risk factor for cardiac arrhythmias including VT and VF.
Heart failure can play a role in the occurrence of ICD shock. In patients where the left ventricular ejection fraction was less than 20%, there is a strong association with receiving a shock. 36 In addition, when the left ventricular ejection fraction is less than 35%, there is a 7 times higher risk of dying, and this risk increases 16-fold when multiple shocks occur. 21 Patients with New York Heart Association class III heart failure are 2 times as likely to receive a shock as people with class I/II. It was also found that if the device had a longer detection time, fewer therapies occurred.
1 New York Heart Association class IV was found to be an independent predictor of appropriate ICD therapy in those with biventricular defibrillators. 38 As seen in other studies, 2, 13 we found that "-blockers seem to exert a modulating influence on the occurrence of ICD shocks, with less than one-third of patients receiving "-blockers received an ICD shock in the first year. Similarly, Hreybe et al 13 in a large cohort of 230 patients with ICD implantation found that the 1-year shock-free survival significantly increased from 48% to 61% in the presence of "-blockers. These data suggest an antiarrhythmic protective effect of "-blockers.
We did not find a significant relationship between anxiety and depression and ICD shocks in the first year. We may have reached this result because StateTrait Anxiety Inventory scores more than or equal to 40 are defined as high anxiety 34 and were used in this analysis. However, high levels of anxiety and the occurrence of ICD shocks approached statistical significance in this analysis, P = .09. Our data suggest that psychological distress at the time of ICD implantation may be related to subsequent ICD shock frequency. Other authors have demonstrated the important relationship between mood disturbance and ICD therapies after controlling for ejection fraction, type of arrhythmia history, and use of antiarrhythmic medications. 15 In addition, concerns about the ICD at the time of implant have also been linked to ICD therapies. 39 Although we did not find smoking to be a significant predictor for the occurrence of ICD shocks, 32% of those who smoked experienced an ICD shock in the first year. Smoking, in addition to being implicated in heart and vascular disease, continues to exact its toll by causing arrhythmias. Although the exact mechanism causing arrhythmias is unknown, 17 when a patient stops smoking, the rates of sudden cardiac death decrease markedly. Sanchez et al 17 reported that 37.5% of patients who smoked had an ICD discharge within the first month after implantation. Smoking was a better predictor of an appropriate ICD discharge than other variables such as age, ejection fraction, QT interval, QRS duration, diabetes, COPD, or use of medications such as ACE inhibitors and "-blocker use. This supports the importance of smoking cessation programs for individuals with an ICD implantation to maximize quality of life and reduce ICD shock occurrence.
Conclusions
It is clear that preventing and avoiding shocks after an ICD are important to reduce mortality, psychological distress, and healthcare utilization. Our data suggest that actions by healthcare providers and patients that could reduce the number of ICD shocks include controlling VT, careful managing of HF symptoms, or perhaps reducing the use of shortacting "-agonist medications in COPD. Attention to the role of anxiety in producing ICD shocks in future investigations is warranted. In addition, stopping smoking, taking "-blocker medications, managing anxiety and depression, treating atrial fibrillation and supraventricular arrhythmias, and closely following up the ICD function to detect device malfunction will potentially reduce ICD shocks. Future studies are needed that prospectively evaluate interventions and treatments to obviate the occurrence of ICD shocks in an effort to provide sound scientific evidence to guide treatment of this particularly vulnerable patient population.
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What's New and Important
h ICD shocks are related to a history of heart failure (HF), history of chronic obstructive pulmonary disease (COPD), and ventricular tachycardia (VT). h Higher levels of anxiety may be associated with ICD shocks. h Individuals at risk for receiving ICD shocks in the first year after an ICD should have close follow-up and individualized ICD programming to prevent unnecessary ICD shocks. h Interventions designed to reduce anxiety may prevent ICD shocks.
